NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 922 filers reported holding NOVARTIS A G in Q2 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,526,000 | +111.7% | 20,545 | +107.5% | 0.05% | +200.0% |
Q4 2016 | $721,000 | -80.8% | 9,900 | -79.2% | 0.02% | -77.6% |
Q3 2016 | $3,758,000 | -29.8% | 47,600 | -26.7% | 0.08% | -16.5% |
Q2 2016 | $5,355,000 | +111.8% | 64,900 | +86.0% | 0.09% | +106.8% |
Q1 2016 | $2,528,000 | +238.4% | 34,895 | +302.1% | 0.04% | +450.0% |
Q4 2015 | $747,000 | -75.9% | 8,679 | -74.3% | 0.01% | -73.3% |
Q3 2015 | $3,099,000 | +313.2% | 33,718 | +343.7% | 0.03% | +328.6% |
Q1 2015 | $750,000 | -79.1% | 7,600 | -80.4% | 0.01% | -68.2% |
Q4 2014 | $3,597,000 | +9.4% | 38,817 | +11.2% | 0.02% | +37.5% |
Q3 2014 | $3,287,000 | -61.5% | 34,921 | -63.0% | 0.02% | -61.0% |
Q2 2014 | $8,540,000 | -32.6% | 94,335 | -36.7% | 0.04% | -42.3% |
Q1 2014 | $12,678,000 | +11.3% | 149,123 | +5.3% | 0.07% | +16.4% |
Q4 2013 | $11,386,000 | +16.6% | 141,647 | +11.2% | 0.06% | +1.7% |
Q3 2013 | $9,769,000 | +64.0% | 127,347 | +51.2% | 0.06% | +62.2% |
Q2 2013 | $5,957,000 | – | 84,247 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 175,039 | $14,610,000 | 5.98% |
MANAGED ASSET PORTFOLIOS, LLC | 211,640 | $17,665,000 | 5.83% |
PRENTISS SMITH & CO INC | 128,894 | $10,759,000 | 5.63% |
SECTORAL ASSET MANAGEMENT INC | 559,296 | $46,684,000 | 5.10% |
Osher Van de Voorde Investment Management | 106,515 | $8,891,000 | 4.74% |
BROWN BROTHERS HARRIMAN & CO | 10,150,549 | $847,266,000 | 4.59% |
Elefante Mark B | 6,019 | $502,000 | 4.06% |
PROFESSIONAL ADVISORY SERVICES INC | 223,738 | $18,675,000 | 4.05% |
First Fiduciary Investment Counsel, Inc. | 245,403 | $20,484,000 | 3.92% |
COMPASS CAPITAL MANAGEMENT, INC | 282,530 | $23,583,000 | 3.84% |